SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) March 12, 2003
---------------------------------------------------------------
EXEGENICS INC.
(Exact name of registrant as specified in its charter)
Delaware 333-26078 75-2402409
(State or Other Jurisdiction (Commission File Number) (I.R.S. Employer
of Incorporation) Identification No.)
2110 Research Row
Dallas, Texas 75235
(Address of principal executive
offices including zip code)
(214) 358-2000
(Registrant's telephone number,
including area code)
N.A.
(Former name or former address, if changed since last report)
Item 5. Other Events.
On March 12, 2003, we issued a press release announcing, among other
things, the election of Joseph M. Davie M.D., Ph.D. to our board of directors
and the appointment of David E. Riggs as Vice President, Chief Business Officer,
Chief Financial Officer and Secretary. A copy of the press release is filed as
Exhibit 99.1 hereto and incorporated herein by reference.
Item 7. Financial Statements and Exhibits
(c) Exhibits.
Exhibit No. Description
99.1 Press Release dated March 12, 2003.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
EXEGENICS INC.
(Registrant)
Dated: March 14, 2003 By: /s/ Ronald L. Goode
--------------------- -------------------------------------
Ronald L. Goode
President and Chief Executive Officer
INDEX TO EXHIBITS
EXHIBIT
NUMBER DESCRIPTION
------- -----------
99.1 Press Release dated March 12, 2003.